GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poseida Therapeutics Inc (STU:2RZ) » Definitions » Long-Term Debt

Poseida Therapeutics (STU:2RZ) Long-Term Debt : €54.00 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Poseida Therapeutics Long-Term Debt?

Poseida Therapeutics's Long-Term Debt for the quarter that ended in Mar. 2024 was €54.00 Mil.

Poseida Therapeutics's quarterly Long-Term Debt declined from Sep. 2023 (€54.81 Mil) to Dec. 2023 (€53.73 Mil) but then increased from Dec. 2023 (€53.73 Mil) to Mar. 2024 (€54.00 Mil).

Poseida Therapeutics's annual Long-Term Debt increased from Dec. 2021 (€25.98 Mil) to Dec. 2022 (€54.99 Mil) but then declined from Dec. 2022 (€54.99 Mil) to Dec. 2023 (€53.73 Mil).

Poseida Therapeutics Long-Term Debt Historical Data

The historical data trend for Poseida Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poseida Therapeutics Long-Term Debt Chart

Poseida Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial 23.53 23.95 25.98 54.99 53.73

Poseida Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.47 53.91 54.81 53.73 54.00

Poseida Therapeutics  (STU:2RZ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Poseida Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Poseida Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Poseida Therapeutics (STU:2RZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poseida Therapeutics Inc (STU:2RZ) » Definitions » Long-Term Debt
Comparable Companies
MACK CBUS DNTH GRTS IVVD CRMD IMRX ATXS INZY AEON OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PSTX:USA
Address
9390 Towne Centre Drive, Suite 200, San Diego, CA, USA, 92121
Website
https://www.poseida.com
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Poseida Therapeutics (STU:2RZ) Headlines

No Headlines